Breaking news from one of our key partners: EggNestβ’
EggNestβ’ Outshines Competitors in Radiation Safety Study. Great to see independent data that demonstrates EggNest's leadership position in protecting the entire team.
Read full article here: https://t.co/SVmxldqQyc
#m3
@M3Medical is excited to be part of #MindtheAorta 2025, a premier event dedicated to advancing aortic disease management and innovation.
π Event Date: 13-14 February 2025
π Location: Rome, Italy
Look forward to seeing you there!
M3 Medical is excited to attend the ABC WIN Seminar from January 12β17, 2025 in France. Renowned for advancing Interventional Neuroradiology, the seminar covers topics like stroke and aneurysms.
Join us to explore innovations and connect with professionals!
Healthcare workers face serious risks from radiation exposure, but our innovative solutions are making lab environments safer than ever.
Explore how weβre supporting those on the frontlines.
@eggmedical#eggnest360#m3medical#radiationreduction
Scatter radiation from x-rays and CT scans poses exposure risks to medical staff. M3 Medical, proud distributor of EggNest, is committed to enhancing healthcare safety with solutions that minimize these risks.
Read more: https://t.co/pNzO2nc0XZ
Great day overall at the Interventional Radiology Nursing Study Day hosted by @MaterRadiology at the Pillar Center for Transformative Healthcare.
Fantastic Turnout - over 50 Nurses from Hospitals all over Ireland.
Join Elixir Medical Corporationβs Webinar on November 15th, βAcute Coronary Syndrome Long-Term Outcomes: Raising the Barβ from 11-12pm (Irish time). This session features groundbreaking data, Singaporean PCI insights, and real-world cases.
Register now: https://t.co/rdDIp05TQm.
We are incredibly grateful to everyone who attended our Endovascular Simulator Demonstration with Ciaran Fitzgerald and Hannah Coakley, our expert clinical specialists from M3 Medical.
M3 Medical is thrilled to partner with experienced vascular surgeons and industry colleagues to launch the inaugural ARC meeting on November 1st.
To register for this course, please email [email protected].
Coronary Care Breakthrough: The Lancet highlights Elixir Medical's DynamX bioadaptor as a promising alternative to DES in PCI, promoting natural artery function with potential for better outcomes. Follow-up will confirm these significant findings.
https://t.co/dvrmpKC3YK